Evidence map›Paper›PMID 39268255›Full record

ArticleCureus2024

Association Between Smoking and Outcomes of Autoimmune Hepatitis.

Marah Alarawi, Mona Alfares, Afrah Alzaraija, Haneen Felemban, Lujain Alzahrani, Nada Almadkhali

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marah AlarawiMedical School, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.
Mona AlfaresInfectious Diseases, King Abdulaziz University Hospital, Jeddah, SAU.
Afrah AlzaraijaMedical School, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.
Haneen FelembanMedical School, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.
Lujain AlzahraniMedical School, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.
Nada AlmadkhaliMedical School, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Autoimmune hepatitis (AIH) is a chronic liver disorder caused by the immune system targeting liver cells. The etiology of AIH remains undefined. Therefore, we aim to explore the relationship between cigarette smoking and AIH.  Methods A retrospective study was done at the Department of Medicine, King Abdulaziz University Hospital (KAUH), Jeddah, Saudi Arabia. Forty-six inpatients and outpatients managed at KAUH from 2016 to 2021 and diagnosed with AIH were included. Data about patients' age, gender, smoking state, type of liver disease, and any other autoimmune disease were collected. Results In all, 10.9% (n = 5) of patients were active smokers, and 60.0% (n = 3) used cigarettes. The median number of cigarettes smoked per day was 17, while 56.5% (n = 26) had a positive family history of smoking, and 41.3% (n = 19) were passive smokers. Of them, 39.1% (n = 18) had at least one complication of AIH, such as liver cirrhosis, which is the most frequent complication (61.1%; n = 11), followed by esophageal varices (22.2%; n = 4), liver fibrosis (5.6%; n = 1), and fatty liver (5.6%; n = 1). The presence of any complication was not associated with patients' demographics or smoking status. On the other hand, liver cirrhosis was significantly higher among currently active smokers. Conclusion No relationship was found between smoking and the AIH outcomes. Future multi-center studies on larger samples are needed.

Indexed as

associationautoimmunecigarettehepatitisoutcomessmoking

Identifiers

PMID39268255
PMCPMC11391490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.